Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells

Rand Arafeh; Karen Flores; Alona Keren-Paz; Galia Maik-Rachline; Naomi Gutkind; Steven Rosenberg; Rony Seger; Yardena Samuels

doi:10.1038/s41598-018-37931-7

Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells

Sci Rep. 2019 Mar 12;9(1):4672. doi: 10.1038/s41598-018-37931-7.

Authors

Rand Arafeh¹, Karen Flores¹, Alona Keren-Paz¹, Galia Maik-Rachline¹, Naomi Gutkind¹, Steven Rosenberg², Rony Seger¹, Yardena Samuels³

Affiliations

¹ Weizmann Institute of Science, Rehovot, Israel.
² National Cancer Institute, NIH, Bethesda, MD, 20892, USA.
³ Weizmann Institute of Science, Rehovot, Israel. yardena.samuels@weizmann.ac.il.

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Publication types

Published Erratum